Pfizer Plans to Launch Remicade Biosimilar in November

Pfizer Inc. plans to start U.S. shipments of biosimilar Inflectra, its copycat version of Johnson& Johnson ’s anti-inflammatory drug Remicade, at a 15% discount to Remicade’s wholesale prices starting in late November.

Source: WSJ.com: Health - October 17, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news